The elevated NLR, PLR and PLT may predict the prognosis of patients with colorectal cancer: a systematic review and meta-analysis

作者：Jie Zhang, Hongying Zhang, Jia Li, Xinyu Shao, Chunxia Zhang · 发表于：Oncotarget · 年份：2017 · DOI：10.18632/oncotarget.18575 · 被引用次数：180 · 研究领域：Inflammatory Biomarkers in Disease Prognosis、Cancer, Lipids, and Metabolism、Venous Thromboembolism Diagnosis and Management

// Jie Zhang 1 , Hong-Ying Zhang 2 , Jia Li 1 , Xin-Yu Shao 3 and Chun-Xia Zhang 1 1 Department of Oncology, The First Affiliated Hospital of Dalian Medical University, Dalian 116011, China 2 Department of Pathology and Forensic Medicine, College of Basic Medical Sciences, Dalian Medical University, Dalian 116044, China 3 Medical Oncology, The First Affiliated Hospital of Dalian Medical University, Dalian 116000, China Correspondence to: Chun-Xia Zhang, email: qm1210@hotmail.com Keywords: colorectal cancer, neutrophils-to-lymphocytes ratio, platelet-to-lymphocytes ratio, platelet counts, prognosis Received: February 24, 2017 Accepted: May 05, 2017 Published: June 19, 2017 ABSTRACT Recently, several studies have reported that inflammatory response and elevated platelet counts may be associated with the poor prognosis of colorectal cancer. This meta-analysis was designed to analyze and evaluate the prognostic role of elevated preoperative or pretreatment neutrophils-to-lymphocytes ratio, platelet-to-lymphocytes ratio or platelet counts in patients with colorectal cancer. We searched PubMed, EMBASE, Cochrane Library and Web of Science to April, 2016. A total of 23 studies ( N = 11762 participants) were included for this meta-analysis. Elevated neutrophils-to-lymphocytes ratio have a close relationship with the poor Overall Survival of colorectal cancer with the pooled HR being 1.92 [95% CI 1.57–2.34; P < 0.00001]. This meta-analysis indicated that elevated neutrophils-to-lymphoc...